- Home
- NEO vs SBGI Comparison
NEO vs SBGI Comparison
Compare NEO & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- SBGI
- Stock Information
- Founded
- NEO 2001
- SBGI 1986
- Country
- NEO United States
- SBGI United States
- Employees
- NEO N/A
- SBGI N/A
- Industry
- NEO Precision Instruments
- SBGI Broadcasting
- Sector
- NEO Health Care
- SBGI Industrials
- Exchange
- NEO Nasdaq
- SBGI Nasdaq
- Market Cap
- NEO 965.2M
- SBGI 997.6M
- IPO Year
- NEO 1999
- SBGI 1995
- Fundamental
- Price
- NEO $7.00
- SBGI $13.67
- Analyst Decision
- NEO Buy
- SBGI Buy
- Analyst Count
- NEO 9
- SBGI 5
- Target Price
- NEO $13.31
- SBGI $18.50
- AVG Volume (30 Days)
- NEO 2.0M
- SBGI 512.5K
- Earning Date
- NEO 07-28-2025
- SBGI 08-06-2025
- Dividend Yield
- NEO N/A
- SBGI 7.40%
- EPS Growth
- NEO N/A
- SBGI N/A
- EPS
- NEO N/A
- SBGI 1.97
- Revenue
- NEO $672,361,000.00
- SBGI $3,526,000,000.00
- Revenue This Year
- NEO $13.97
- SBGI N/A
- Revenue Next Year
- NEO $11.36
- SBGI $9.59
- P/E Ratio
- NEO N/A
- SBGI $6.88
- Revenue Growth
- NEO 10.10
- SBGI 11.62
- 52 Week Low
- NEO $6.08
- SBGI $11.13
- 52 Week High
- NEO $19.12
- SBGI $18.46
- Technical
- Relative Strength Index (RSI)
- NEO 40.74
- SBGI 48.16
- Support Level
- NEO $6.90
- SBGI $12.79
- Resistance Level
- NEO $7.42
- SBGI $13.40
- Average True Range (ATR)
- NEO 0.39
- SBGI 0.46
- MACD
- NEO -0.00
- SBGI 0.03
- Stochastic Oscillator
- NEO 13.01
- SBGI 69.10
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their content to pay-TV distributors.